The 7 major Diffuse Large B-cell Lymphoma (DLBCL) markets reached a value of USD 4,013.3 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 5,405.9 Million by 2035, exhibiting a growth rate (CAGR) of 2.8% during 2025-2035. for...
imarcmarketresearch.hashnode.dev4 min readNo responses yet.